LSC Recent Webinars on BIO

1. How Connected Digital Execution Turns Pharma Data Into Decisions 4/30/2026

   Disconnected systems slow investigations and delay batch release. Learn how a digitally connected execution ecosystem provides real-time context for alerts, enabling proactive control and faster decisions.

2. Engineering Precision In Genetic Medicines 4/30/2026

   Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.

3. From DNA To IND In As Little As 6 Months 4/27/2026

   Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.

4. Biologics Tech Transfer & Validation at Scale: A Better Path to GMP 4/24/2026

   Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.

5. Advancing In-Line PAT Solutions For Real-Time Batch Analysis 4/23/2026

   Shift from reactive sampling to continuous, data-driven control. Learn how in-line metabolic monitoring improves yield and batch consistency through real-time glucose and lactate insights.

6. Unlocking The Next Wave Of Cancer Vaccines 4/21/2026

   Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.

7. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

   See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

8. EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation 4/16/2026

   Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.

9. OneTeam™: Setting A New Standard for Biotech Program Visibility 4/15/2026

   An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.

10. Less Risk, More Speed -The New Blueprint For Bioconjugate Development 4/15/2026

    A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.